FdaApplication
NDA 210192
Identifiers
- fda_app_no: NDA210192
Properties
| Property | Value |
|---|---|
| applicant_name | VIIV HEALTHCARE CO |
| application_type | NDA |
| approval_date | 2017-11-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | EQ 50MG BASE;EQ 25MG BASE | TABLET;ORAL |
1 product